PT Darya-Varia Laboratoria Tbk

DVLA

ID1000117203

Pharmaceuticals

End-of-day quote INDONESIA S.E. Other stock markets 03:30:00 07/06/2024 am IST			5-day change	1st Jan Change
1,570 ^IDR	+0.96%		+1.95%	-5.71%

29/04	PT Darya-Varia Laboratoria Tbk Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
22/03	PT Darya-Varia Laboratoria Tbk Reports Earnings Results for the Full Year Ended December 31, 2023	CI

PT Darya-Varia Laboratoria Tbk Announces New Office

September 01, 2016 at 03:14 pm IST

As of October 3rd, 2016, Operational Office of PT Darya-Varia Laboratoria Tbk will be moved to a new location as follows: PT Darya-Varia Laboratoria Tbk, South Quarter Tower C, 18th-19th Floor, Jl. R. A Kartini, Kav. 8, Jakarta 12430.

Latest news about PT Darya-Varia Laboratoria Tbk

PT Darya-Varia Laboratoria Tbk Reports Earnings Results for the First Quarter Ended March 31, 2024	29/04	CI
PT Darya-Varia Laboratoria Tbk Reports Earnings Results for the Full Year Ended December 31, 2023	22/03	CI
PT Darya-Varia Laboratoria Tbk Reports Earnings Results for the Nine Months Ended September 30, 2023	27/23/27	CI
PT Darya-Varia Laboratoria Tbk Reports Earnings Results for the Half Year Ended June 30, 2023	28/23/28	CI
PT Darya-Varia Laboratoria Tbk Reports Earnings Results for the First Quarter Ended March 31, 2023	27/23/27	CI
PT Darya-Varia Laboratoria Tbk Reports Earnings Results for the Full Year Ended December 31, 2022	31/23/31	CI
PT Darya-Varia Laboratoria Tbk Reports Earnings Results for the Nine Months Ended September 30, 2022	15/22/15	CI
PT Darya-Varia Laboratoria Tbk Reports Earnings Results for the Half Year Ended June 30, 2022	23/22/23	CI
PT Darya-Varia Laboratoria Tbk Reports Earnings Results for the First Quarter Ended March 31, 2022	30/22/30	CI
PT Darya-Varia Laboratoria Tbk Reports Earnings Results for the Full Year Ended December 31, 2021	21/22/21	CI
PT Darya-Varia Laboratoria Tbk Reports Earnings Results for the Nine Months Ended September 30, 2021	19/21/19	CI
Pt Darya-Varia Laboratoria Tbk Reports Earnings Results for the Half Year Ended June 30, 2021	27/21/27	CI
Pt Darya-Varia Laboratoria Tbk Reports Earnings Results for the Full Year Ended December 31, 2020	24/21/24	CI
Pt Darya-Varia Laboratoria Tbk Reports Earnings Results for the Half Year Ended June 30, 2020	29/20/29	CI
PT Darya-Varia Laboratoria Tbk Launches New Variant, Natur-E White Series	12/20/12	CI
Pt Darya-Varia Laboratoria Tbk Reports Earnings Results for the Full Year Ended December 31, 2019	01/20/01	CI
Pt Darya-Varia Laboratoria Tbk Reports Earnings Results for the Nine Months Ended September 30, 2019	29/19/29	CI
PT Darya-Varia Laboratoria Tbk Reports Earnings Results for the Half Year Ended June 30, 2019	30/19/30	CI
Pt Darya-Varia Laboratoria Tbk Reports Earnings Results for the First Quarter Ended March 31, 2019	30/19/30	CI
PT Etana Biotechnologies Indonesia announced that it has received IDR 34.302 billion in funding from PT Darya-Varia Laboratoria Tbk, Etana Biotechnologies Hong Kong Limited	21/18/21	CI
PT Etana Biotechnologies Indonesia announced that it expects to receive IDR 34.302 billion in funding from PT Darya-Varia Laboratoria Tbk, Etana Biotechnologies Hong Kong Limited	05/18/05	CI
PT Darya-Varia Laboratoria Tbk Announces New Office	01/16/01	CI
An unknown buyer acquired 0.54% stake in PT Darya-Varia Laboratoria Tbk from Blue Sphere Singapore Pte. Ltd. for $0.57 million.	26/16/26	CI
Tranche Update on PT Darya-Varia Laboratoria Tbk's Equity Buyback Plan announced on June 16, 2014.	03/14/03	CI
PT Darya-Varia Laboratoria Tbk completed the acquisition of the remaining stake in PT Pradja Pharin from Marlia Hayati Goestam.	07/14/07	CI

Chart PT Darya-Varia Laboratoria Tbk

Duration

Period

More charts

Company Profile

PT Darya-Varia Laboratoria Tbk is an Indonesia-based pharmaceutical company. Its segments include prescription drugs, consumer health products, export and toll manufacturing services and services. Its consumer health products include skin nutrition, respiratory, vitamins and daily relief. Its prescription products include Daryaven, Urdafalk and Aspilets. Through its multivitamin brands, such as Enervon-C, Enervon Active, Enervon Gold and Supertin, it helps to boost body immune and maintain health. It also provides Imunped as a supplement for kids with Zinc and vitamin C, which are essential for children. Its Forti-D 1000 IU is a health supplement (vitamin) product. Fortagyl provides prevention and treatment of amoebiasis, trichomoniasis, giardiasis and post-operation infections. It provides toll manufacturing services for both local and international principals with its two manufacturing facilities: Gunung Putri and Citeureup manufacturing facilities.

Sector

Pharmaceuticals

Calendar

22/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
PT DARYA-VARIA LABORATORIA TBK	-5.71%	109M
ELI LILLY AND COMPANY	+45.82%	765B
NOVO NORDISK A/S	+40.95%	632B
JOHNSON & JOHNSON	-6.16%	354B
MERCK & CO., INC.	+19.86%	331B
ABBVIE INC.	+9.32%	299B
ASTRAZENECA PLC	+18.45%	248B
ROCHE HOLDING AG	-0.78%	219B
NOVARTIS AG	+11.88%	216B
AMGEN INC.	+5.90%	164B